Are Pecans Good for Weight Loss? Honest Evidence Review

The honest answer: yes in 1-oz portions. Pecans are one of the most calorie-dense foods on the planet (~691 kcal per 100 g, the highest of any common tree nut after macadamia) — but the long-term cohort epidemiology doesn't bear out the intuitive concern. Per USDA FoodData Central (FDC 170182^[10]), 100 g of pecans delivers ~691 kcal, ~9 g protein, ~72 g fat (~41 g monounsaturated oleic acid — the same fat profile as olive oil and avocado), ~14 g carbohydrate of which ~10 g is dietary fiber, and rich micronutrient density: ~410 mg potassium, ~121 mg magnesium, ~4.5 mg manganese, plus unusually high gamma-tocopherol vitamin E content. The Mozaffarian 2011 NEJM analysis^[1] of 120,877 US adults across three Harvard cohorts found nuts associated with −0.57 lb of 4-year weight change per daily serving increase — among the small set of foods (alongside yogurt, fruits, vegetables, whole grains) that were inversely associated with long-term weight gain. The pecan-specific RCT evidence is thin but converging: Cogan 2023 Clin Nutr ESPEN^[7] randomized adults to 68 g/day of pecans replacing isocaloric typical-diet calories for 8 weeks; postprandial peptide YY (the satiety hormone) was elevated and subjective appetite intensity was reduced vs control. The companion Cogan 2023 Nutr Res trial^[6] in older adults showed LDL-cholesterol and total cholesterol improvements on the same pecan-substitution protocol. The Aune 2016 BMC Med meta-analysis^[5] across prospective cohorts found ~28 g/day of nuts associated with ~21% lower coronary heart disease risk and ~22% lower all-cause mortality. The deciding variable: portion size. A measured 1-oz (28 g) serving is ~19 pecan halves and ~196 kcal — portion-controllable. Grabbing a handful from an open bag commonly runs 3–4 oz (~600–800 kcal in one sitting) and is the dominant failure mode. The calorie-density-vs-cohort-data paradox resolves via two mechanisms: nut structure reduces metabolizable energy below Atwater-predicted values (Gebauer 2016^[3] showed almonds yield ~25% less absorbed energy than label calories, and the same intact-cell-wall principle applies broadly to tree nuts including pecans), and the fat-fiber-protein matrix produces strong meal-by-meal satiety that drives spontaneous energy compensation at later meals. Magnitude check: STEP-1 semaglutide^[8] −14.9% body weight at 68 weeks; SURMOUNT-1 tirzepatide^[9] −20.9% at 72 weeks. Pecans are not pharmacotherapy — no food is — but they are a portion-controllable, high-satiety, cardio-protective whole-food fat source that survives weight- loss eating when the portion is measured.

At a glance

• USDA per 100 g (FDC 170182^[10]): ~691 kcal, 9 g protein, 72 g fat (41 g MUFA, 22 g PUFA, 6 g SFA), 14 g carbohydrate, 10 g fiber, 0 mg sodium, 410 mg potassium, 121 mg magnesium, 4.5 mg manganese.
• Per 1-oz (28 g, ~19 halves) reference serving: ~196 kcal, ~2.6 g protein, ~20.4 g fat (~11.6 g MUFA), ~3.9 g carbohydrate, ~2.7 g fiber. The load-bearing portion size for weight-loss-compatible pecan eating.
• Mozaffarian 2011 NEJM^[1], n=120,877: nuts inversely associated with 4-year weight change at −0.57 lb per daily-serving increase — landing alongside yogurt and fruits on the protective side, opposite potato chips (+1.69 lb) and SSBs (+1.00 lb).
• Cogan 2023 Clin Nutr ESPEN pecan PYY RCT^[7]: 8-week pecan-substitution trial increased postprandial PYY secretion and reduced subjective appetite intensity vs isocaloric control diet. Pecan- specific satiety mechanism evidence.
• Cogan 2023 Nutr Res pecan-cholesterol RCT^[6]: 68 g/day of pecans for 8 weeks reduced LDL-cholesterol and total cholesterol in older adults vs isocaloric typical-diet control.
• Aune 2016 BMC Med nut meta-analysis^[5]: ~28 g/day of nuts (any type) associated with ~21% lower CHD risk and ~22% lower all-cause mortality across prospective cohorts.
• Magnitude vs GLP-1s: STEP-1 semaglutide^[8] −14.9% body weight at 68 weeks; SURMOUNT-1 tirzepatide^[9] −20.9% at 72 weeks. Pecans do not approach this magnitude — no food does.

Why pecans (and nuts generally) don't drive weight gain despite being calorie-dense

The intuitive case against pecans for weight loss is simple: 691 kcal per 100 g makes them one of the most calorie-dense common foods, second only to macadamia (~718 kcal/100 g) among tree nuts and ahead of walnuts (~654 kcal), almonds (~579 kcal), and peanuts (~567 kcal). A casual handful is easily 3–4 ounces; the napkin-math fear is real.

The cohort evidence does not bear that fear out. The Mozaffarian 2011 NEJM paper^[1] tracked 120,877 US adults across the Nurses' Health Study, NHS-II, and Health Professionals Follow-up Study with 4-year follow-up intervals. Foods most positively associated with 4-year weight gain per daily serving increase: potato chips (+1.69 lb), potatoes (+1.28 lb), sugar-sweetened beverages (+1.00 lb), unprocessed red meats (+0.95 lb), processed meats (+0.93 lb). Foods most inversely associated: yogurt (−0.82 lb), nuts (−0.57 lb), fruits (−0.49 lb), whole grains (−0.37 lb), vegetables (−0.22 lb). Nuts landed firmly on the protective side — ahead of fruits, whole grains, and vegetables on a per-serving basis. This signal is reinforced by the Aune 2016 BMC Med dose-response meta-analysis^[5] across prospective cohorts: ~28 g/day of nut intake (one ounce) associated with ~21% lower coronary heart disease risk, ~15% lower stroke risk, and ~22% lower all-cause mortality. The Balakrishna 2022 Adv Nutr umbrella review^[4] synthesized these signals across nut and seed consumption broadly: consistent inverse associations with CVD, type 2 diabetes, all-cause mortality, and select cancers.

The standard observational-nutrition caveats apply: people who eat more nuts likely cluster with other health-positive behaviors. But the consistency across cohorts, populations, and study designs — combined with the mechanistic RCT evidence on energy compensation and bioavailability — makes nuts one of the better-evidenced “safe” calorie-dense foods in the weight-management literature.

Pecans nutrition: where they fit among nuts

Fat profile is favorable. Of the ~72 g of fat per 100 g of pecans, ~41 g is monounsaturated (predominantly oleic acid, the same fatty acid that dominates olive oil and avocado), ~22 g is polyunsaturated, and only ~6 g is saturated. The MUFA-dominant profile is what underpins the cardiometabolic signal in the cohort data.

Protein density is modest. At ~9 g of protein per 100 g, pecans are among the lowest-protein common nuts — well below peanuts (~26 g, technically a legume), almonds (~21 g), pistachios (~20 g), and cashews (~18 g). Pecans are not a protein anchor. They are a fat-and-fiber food with meaningful micronutrient density, similar in role to avocado.

Fiber is substantial. ~10 g of fiber per 100 g (~2.7 g per 1-oz serving) is high among nuts — tied with almonds and pistachios. The fat-and-fiber combination is what drives the satiety signal documented in Cogan 2023^[7].

Micronutrient profile is notable. Pecans are among the richest food sources of gamma-tocopherol (a less common form of vitamin E with distinct antioxidant properties), and they contribute meaningful magnesium (~121 mg/100 g), manganese (~4.5 mg/100 g — nearly twice the daily reference value per ounce), zinc, and copper.

The nut-bioavailability gap: you don't absorb all the calories

The Atwater system — the 4-9-4 kcal-per-gram values for protein-fat-carbohydrate that USDA food databases rely on — was developed in the early 1900s and assumes complete macronutrient absorption. For most foods this is a reasonable approximation. For whole tree nuts it is not.

Gebauer 2016 Food Funct^[3] — the most rigorous published metabolizable-energy study on tree nuts — used whole-body indirect calorimetry plus fecal bomb-calorimetry collection to measure actual energy extraction from almonds in human subjects. Whole almonds yielded ~129 kcal per 28 g serving against an Atwater- predicted ~173 kcal — a ~25% gap. The mechanism is intact plant-cell-wall structure: a meaningful fraction of the embedded fat escapes lipase digestion in the small intestine and is excreted in feces. Almond butter, finely chopped almonds, and roasted almonds all narrow that gap because cell-wall integrity is disrupted; whole raw almonds show the largest bioavailability gap.

Pecan-specific metabolizable-energy studies are thinner — the published bioavailability literature is dominated by almonds, pistachios, and walnuts — but the underlying mechanism (intact lipid-rich cells inside a cellulose matrix) applies to pecans. The honest read is that a 1-oz serving of whole pecans labelled at 196 kcal likely delivers somewhat fewer absorbed calories (best published estimates for tree nuts range from a 5–25% gap depending on processing), with the gap closing for finely ground products like pecan flour or pecan butter. This is not a license to ignore portion size — the absolute calorie load is still material — but it does explain part of why nut-heavy diets in cohort studies don't produce the weight gain that label calories would predict.

Heart-health evidence and cholesterol profile

The cardiometabolic evidence for pecans converges from two directions: the broad nut meta-analyses and the small but growing pecan-specific RCT literature.

Aune 2016 BMC Med dose-response meta-analysis^[5] pooled prospective cohort data on nut consumption across populations. Each 28-g/day increment in nut intake was associated with:

• ~21% lower coronary heart disease risk
• ~15% lower stroke risk
• ~22% lower all-cause mortality
• ~17% lower cardiovascular mortality
• ~15% lower cancer mortality

The Balakrishna 2022 Adv Nutr umbrella review^[4] synthesized published systematic reviews on nut and seed consumption, finding consistent inverse associations with type 2 diabetes incidence, metabolic syndrome, CVD events, and all-cause mortality. The signal is unusually robust across nut types, dose levels, and study designs.

Cogan 2023 Nutr Res pecan-substitution RCT^[6] is the most pecan-specific published trial. Older adults were randomized to either a pecan-enriched diet (~68 g/day, replacing isocaloric typical- diet calories) or a control diet for 8 weeks. The pecan arm showed reductions in LDL-cholesterol and total cholesterol vs control, plus improved postprandial microvascular reactivity — consistent with the favorable MUFA- dominant fat profile of pecans (~41 g MUFA per 100 g, the same oleic-acid-dominant pattern as olive oil and avocado). The 68 g/day intervention dose is meaningfully higher than the 28 g/day pragmatic serving but anchors the mechanistic signal.

Pecans are also notable for gamma-tocopherol content — a form of vitamin E less studied than alpha-tocopherol but with distinct antioxidant chemistry against reactive nitrogen species. The micronutrient density (gamma- tocopherol, magnesium, manganese, zinc, copper) supplies a plausible secondary mechanism for the cardiometabolic signal alongside the direct lipid effects.

The pecan satiety signal

The Cogan 2023 Clin Nutr ESPEN trial^[7] is the first published RCT to directly measure pecan effects on satiety hormones in humans. Adults randomized to 8 weeks of pecan substitution (68 g/day replacing isocaloric typical- diet calories) showed:

• Elevated postprandial peptide YY (PYY) secretion — the gut hormone released by L-cells in the distal small intestine and colon that signals satiety to the central nervous system. PYY is the same hormone family implicated in the satiety response to high-protein meals and to fiber-rich foods.
• Reduced subjective appetite intensity ratings vs control on standardized visual analog scales.
• No compensatory increase in non-pecan food intake over the trial period — consistent with the broader nut- energy-compensation literature (Alper & Mattes 2002 on peanuts is the classic reference).

The mechanism is the fat-and-fiber combination: ~20 g of fat plus ~3 g of fiber per 1-oz serving slows gastric emptying, prolongs L-cell stimulation in the lower intestine, and sustains PYY release. The chewing-resistance of whole pecans adds a behavioral satiety component (vs ground or buttered forms). This is the same fat-fiber-chewing satiety pattern documented across the tree-nut RCT literature.

Pecans are not on the Holt 1995 satiety index^[2] — that 1995 protocol tested 38 common foods at standardized 240-kcal portions against white bread = 100, and tree nuts were not in the panel. Peanuts were tested at an index of 84 (below white bread, attributed to high palatability and low chewing-resistance for a roasted salted nut). Whole raw pecans likely score similarly or modestly higher given the equivalent fat-and-fiber matrix plus the harder chewing-resistance — but this is inference, not direct measurement.

Where pecans help GLP-1 patients specifically

For patients on semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro), pecans have specific practical attributes worth flagging:

• Small physical volume. 1 oz of pecans (~19 halves) is ~40 mL by volume. GLP-1-induced delayed gastric emptying makes high-volume foods uncomfortable; a small, calorie-dense, nutrient-dense handful is often better tolerated than 1.5 cups of Greek yogurt or 4 oz of chicken, especially in the nausea-dominant titration phase.
• Mineral density complements appetite suppression. GLP-1 patients often eat substantially less total food and risk magnesium, manganese, and zinc shortfalls. 1 oz of pecans delivers ~34 mg magnesium (~8% DRV), ~1.3 mg manganese (~57% DRV), and meaningful zinc and copper — a high micronutrient-per-bite ratio that survives reduced total intake.
• Calorie density is still a trap. On a typical GLP-1 reduced intake of 1,200–1,500 kcal/day, a single 1-oz serving is 13–16% of daily calories. A three-handful evening graze (~3 oz, ~600 kcal) is ~40% of daily intake from a single non-protein-anchored food — not catastrophic, but a real opportunity cost vs spending those calories on a complete protein source like eggs, cottage cheese, or whey.
• Pair with a protein anchor. Pecans are fat-and-fiber, not protein-dense. The honest pattern is pecans as a high-satiety side or topping (on cottage cheese, on Greek yogurt, on a salad with grilled chicken or salmon, or stirred into oatmeal with peanut butter), not as a meal in themselves.
• Gastric-emptying interaction. Pecans are very high-fat per bite (~20 g fat per 1-oz serving). High- fat foods further prolong gastric emptying on a GLP-1 and can worsen nausea in symptomatic patients. A measured 1-oz serving is generally well-tolerated; a 3–4 oz graze can push past individual tolerance.

See our GLP-1 side effect questions answered hub for the broader gastric-emptying and nausea management context, and our semaglutide and muscle mass loss review for the lean-mass-preservation framework where higher- protein options (cottage cheese, Greek yogurt, eggs, fish, whey) anchor and pecans complement.

1-oz portion math: how to actually eat pecans for weight loss

The single variable that determines whether pecans are weight-loss compatible is portion size. The math is simple and the failure mode is consistent.

What a real 1-oz serving looks like: 28 g, approximately 19 pecan halves, ~196 kcal. Pre-portioned into a small container or counted out as halves on a napkin, this portion is unambiguous and satisfying.

Common real-world portions:

• 1/4 oz (7 g, ~5 halves): ~49 kcal. Useful as a topping (on salad, oatmeal, yogurt).
• 1 oz (28 g, ~19 halves, USDA reference): ~196 kcal, 2.7 g fiber. The Mozaffarian 2011 cohort per-daily-serving-increase reference dose.
• 2 oz (56 g, ~38 halves): ~392 kcal. A generous snack — reasonable for an active day or as a meal-anchor add-on, still inside the cohort range.
• “Handful” eyeball estimate (~50–80 g): ~350–550 kcal. Variable; the dominant unmeasured-portion failure mode.
• “Snack out of the bag while watching TV” (~100–150 g): ~700–1,040 kcal in one sitting. Pecans plus distraction plus open packaging reliably produces this pattern.

The pragmatic rule: pre-portion pecans into small containers or zip-top bags (1 oz each, ~19 halves) when buying the family-size bag. The single most common pecan-driven calorie drift is unmeasured grazing directly from the resealable bag.

Pecan pie, butter pecan ice cream, candied pecans: the calorie trap

Most US pecan consumption is not whole-nut consumption. Pecans are the centerpiece of several extremely calorie- dense sweetened preparations that share a name with the whole-food evidence base but have a very different macro profile.

• Pecan pie (1 slice, ~113 g): ~500– 580 kcal, ~25 g fat, ~65 g carbohydrate, ~40 g sugar (corn syrup or molasses + brown sugar). The pecans are a small fraction of the slice; the calorie load is mostly added sugar. This is dessert, not a nut.
• Butter pecan ice cream (1/2 cup, ~65 g): ~280–320 kcal, ~17 g fat, ~28 g carb, ~22 g sugar. Most of the fat is dairy fat; the pecans are a flavor accent. The added-sugar profile is the load-bearing macro.
• Candied / praline / honey-glazed pecans (1 oz, 28 g): ~150–180 kcal of pecans + 50–80 kcal of added sugar/honey/butter glaze = ~200–260 kcal per ounce. Higher palatability translates to easier over-consumption. The cohort evidence on nuts and weight gain does not extend to candied preparations.
• Pecan-encrusted protein dishes (pecan-crusted salmon, pecan-crusted chicken): generally a clean use case if the pecans are a thin crust (~0.5 oz per serving, ~100 kcal added) on a lean protein base.
• Pecan butter (1 tbsp, ~16 g): ~110 kcal, ~11 g fat, ~1 g protein, ~1 g fiber. Similar macro density to other nut butters; somewhat lower protein per calorie than peanut or almond butter. Useful as a spread; less favorable than peanut butter as a protein contributor.

The weight-loss-compatible pecan use case is whole pecans, measured to 1 oz, eaten as a topping or standalone snack with a protein anchor nearby. Pecan pie and butter pecan ice cream are dessert categories with pecan as a flavor accent; the calorie load is the sugar profile, not the nut.

Pecans vs peanuts vs walnuts vs almonds: brief side-by-side

Among the common nuts on US supermarket shelves, pecans occupy a specific niche: high fat, modest protein, high fiber, very high MUFA dominance. Quick comparison per 100 g (USDA FoodData Central^[10]):

• Pecans: 691 kcal, 9 g protein, 72 g fat (41 g MUFA), 14 g carb, 10 g fiber. Highest MUFA percent; lowest protein among common nuts; high gamma-tocopherol. Best fit: cardio-protective fat-and-fiber food, side or topping role.
• Peanuts (technically a legume): 567 kcal, 26 g protein, 49 g fat, 16 g carb, 9 g fiber. Highest protein density; best protein-per-kcal among common nuts (~21 kcal/g protein). Best fit: protein contributor + satiety food.
• Walnuts: 654 kcal, 15 g protein, 65 g fat (47 g PUFA dominated by ALA omega-3), 14 g carb, 7 g fiber. The only common nut with substantial plant omega-3. Best fit: omega-3 contributor + cardio-protective food.
• Almonds: 579 kcal, 21 g protein, 50 g fat (32 g MUFA), 22 g carb, 13 g fiber. Highest fiber among common nuts; high protein; lowest calorie density per gram. Best documented bioavailability gap (Gebauer 2016^[3]). Best fit: highest-fiber-per-bite calorie-controlled nut.
• Pistachios: 560 kcal, 20 g protein, 45 g fat, 28 g carb, 10 g fiber. Strong protein density; shell-on form adds behavioral portion control.

For a fixed calorie budget on a weight-loss eating pattern: peanuts and almonds offer the highest protein-per-kcal and deserve priority as protein contributors. Walnuts offer the unique omega-3 contribution. Pecans are the cardio- protective MUFA-dominant side with the strongest pecan- specific RCT signal on satiety hormones and cholesterol (Cogan 2023, both trials^[6][7]). Variety across nut types within the 1-oz/day pragmatic range gets you all the benefits without locking in to a single profile.

Bottom line

• Pecans are calorie-dense (~691 kcal per 100 g, ~196 kcal per 1-oz serving of ~19 halves per USDA FoodData Central FDC 170182^[10]), but the nut-and-weight-gain epidemiology does not bear out the intuitive concern.
• The Mozaffarian 2011 NEJM Harvard-cohort analysis^[1] of 120,877 adults found nuts inversely associated with 4-year weight gain at −0.57 lb per daily-serving increase — alongside yogurt, fruits, vegetables, and whole grains on the protective side of the food-by-food benchmarking.
• The Aune 2016 BMC Med meta-analysis^[5] across prospective cohorts found ~28 g/day of nuts associated with ~21% lower CHD risk and ~22% lower all-cause mortality — the cardiometabolic signal is unusually robust.
• Cogan 2023 Clin Nutr ESPEN^[7] is the first pecan-specific RCT to measure satiety hormones: 68 g/day of pecans for 8 weeks elevated postprandial PYY secretion and reduced subjective appetite intensity vs isocaloric control. The companion Cogan 2023 Nutr Res trial^[6] on the same protocol showed LDL-cholesterol and total-cholesterol improvements in older adults.
• The nut-bioavailability gap is real: the Gebauer 2016 Food Funct study^[3] on almonds documented ~25% less metabolizable energy from whole almonds vs Atwater prediction. Pecan-specific bioavailability data are thinner, but the same intact-cell-wall mechanism applies.
• Portion control is the deciding variable. A 1-oz (28 g, ~19 halves) measured serving is ~196 kcal; an unmeasured handful is commonly 50–80 g (~350–550 kcal); snacking directly from the resealable bag while distracted can hit 100–150 g (~700–1,040 kcal) in one sitting. The cohort and RCT evidence is at the 28–68 g/day intake level, not the uncontrolled-graze level.
• Pecans are not a protein anchor (~9 g protein per 100 g, the lowest among common nuts). Pair them with cottage cheese, Greek yogurt, eggs, fish, lean meat, or whey protein for the protein-density side; pecans contribute fat, fiber, MUFA cardio-protection, and high micronutrient density.
• For GLP-1 patients: small physical volume, high micronutrient density per bite, modest protein. Pair with a complete protein source rather than treating pecans as the centerpiece. Test individual tolerance for high-fat foods during nausea-dominant titration weeks.
• Magnitude: STEP-1 semaglutide^[8] −14.9% body weight at 68 weeks. SURMOUNT-1 tirzepatide^[9] −20.9% at 72 weeks. The food-side magnitude does not approach pharmacotherapy. Pecans are a portion-controllable, cardio-protective, high-satiety food that survives weight-loss eating — not a weight-loss intervention.
• The verdict: yes in 1-oz portions. Pecans belong in the “cleared by the evidence” column for weight- loss-compatible foods, with the explicit caveats that the portion is what matters and pecan pie / butter pecan ice cream / candied pecans are a different food in practice.

Related research and tools

• Is peanut butter good for weight loss? — the high-protein nut-butter sibling. Peanuts deliver ~26 g protein per 100 g vs pecans' ~9 g; peanut butter is the protein-anchor option, pecans are the fat-fiber- MUFA side.
• Is avocado good for weight loss? — the other MUFA-dominant whole-food fat source. Avocado is fiber-and-water; pecans are fat-and-fiber. Both fit inside a calorie deficit; both reward measured portions.
• Is cottage cheese good for weight loss? — the canonical high-protein-per-kcal pairing. 1/2 cup cottage cheese + 1/4 oz pecan halves + sliced apple is a ~180-kcal snack with 14 g protein.
• Is steak good for weight loss? — the dinner-side animal-protein anchor where pecans fit as a salad-topping or vegetable-side accent.
• Is chicken and rice good for weight loss? — the canonical weight-loss meal-prep template. 1/4 oz of pecans on top of a chicken-and-greens bowl is ~50 kcal of crunch that doesn't derail the macros.
• Are protein shakes good for weight loss? — the most protein-per-kcal-efficient option for lean-mass preservation. Pecans are a flavor/fat add-on, not a protein substitute.
• Best protein powder for weight loss on a GLP-1 — the lean-mass-preservation context. Pecan protein density (~9 g per 100 g) is too low to anchor; pair with a whey or casein source.
• Which fruits are good for weight loss? Evidence hub — the apple-and-nut pairing context (an apple + 1 oz of pecans is a classic ~280 kcal high-satiety snack with 7 g fiber).
• Semaglutide and muscle mass loss — the SURMOUNT-1 DXA evidence that makes the protein- quality argument; pecans contribute but do not anchor.
• GLP-1 side effect questions answered — the nausea and delayed-gastric-emptying management hub where high-fat foods like pecans need individual- tolerance testing during titration.
• Zepbound (tirzepatide) — SURMOUNT-1 magnitude reference (−20.9% body weight at 72 weeks)
• Wegovy (semaglutide) — STEP-1 magnitude reference (−14.9% body weight at 68 weeks)
• GLP-1 protein calculator — calculate your daily protein target (1.6–2.2 g/kg) for lean-mass preservation. 1 oz of pecans contributes only ~2.6 g of protein toward that target — useful as a fat/fiber side, not a protein anchor.

Important disclaimer. This article is educational and does not constitute medical or nutrition advice. Patients with tree-nut allergy must strictly avoid pecans and pecan-containing products; cross-reactivity with walnut allergy is common (both are in the Juglandaceae family). Patients on semaglutide, tirzepatide, or other GLP-1 receptor agonists in the nausea-dominant phase of titration should test individual tolerance to high-fat foods like pecans with small portions, since high-fat meals can further prolong gastric emptying. Patients with diagnosed gastroparesis should discuss high-fat-food tolerance with their clinician. Pecans are calorie-dense and easy to over-consume in unmeasured portions; the pragmatic-eating evidence is at the 28–68 g/day intake level documented in the published trials. PMIDs were independently verified against the PubMed E-utilities API on 2026-05-21; per-100-g nutrient values are drawn from USDA FoodData Central and carry typical food-database variance.

Last verified: 2026-05-21. Next review: every 12 months, or sooner if major new evidence on pecan consumption, body weight, or cardiometabolic outcomes is published.